AI-Controlled Drone Goes Rogue, “Kills” Human Operator In Simulated US Air Force Test ZeroHedge 
Target Plunges For 10th Day As Boycott Leads To “Traffic Weakness”, JPM Downgrade Adds To Groom And Doom ZeroHedge 
Main Street deals welcomed on VC platforms 
Musk’s Brain Implant Startup Receives FDA Approval For Human Tests ZeroHedge 
Crypto Carnage Continues As Stablecoin Crisis Spreads To Tether | ZeroHedge
From: zerohedge Crypto Carnage Continues As Stablecoin Crisis Spreads To Tether | ZeroHedge The market capitalization of the world's cryptocurrencies...
Applied Blockchain stock slides in wake $40M IPO, Nasdaq uplisting
By Val Kennedy, Applied Blockchain (APLD) stock tumbled 10% Thursday, a little over a week after the company...
Lung cancer test developer BioAffinity files for $19M IPO
By Val Kennedy, BioAffinity Technologies (BIAF), which is developing a test to better detect lung cancer in its...
Norovirus vaccine developer HilleVax upsizes proposed IPO to $175M
By Val Kennedy, Novovirus vaccine developer HilleVax (HLVX) has upsized its initial public offering to $175M from $100M. The...
ClimateRock prices $75M IPO, trading starts today
By Khyathi Dalal, ClimateRock (CLRC) priced its 7.5M units IPO at an offer price of $10/unit; each unit consists of one Class...
All eyes on me: Leading eyecare company Bausch + Lomb sets terms for $788 million dual listing in the US and Canada
By Renaissance Capital, Bausch + Lomb, a leading supplier of contact lenses and eyecare products, announced terms for its IPO...
US IPO Week Ahead: Bausch + Lomb plans the second largest IPO of 2022
By Renaissance Capital, In what would be the second largest IPO of the year, eyecare company Bausch + Lomb (BLCO) is scheduled...
Biotech SPAC Bellevue Life Sciences Acquisition files for a $60 million IPO
By Renaissance Capital, Bellevue Life Sciences Acquisition, a blank check company backed by Bellevue Capital Management targeting the biotech sector,...
Hong Kong-based Magic Empire Global Limited files and sets terms for a $23 million US IPO
By Renaissance Capital, Magic Empire Global Limited, a Hong Kong-based provider of financial advisory and underwriting services, filed on Friday...
Norovirus vaccine developer HilleVax stock climbs 10% following upsized $200M IPO
By Val kennedy, Norovirus vaccine developer HilleVax (HLVX) shares rose 10% following its upsized $200M initial public offering....